Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCARPH: Nifedipine vs Labetalol for Postpartum Hypertension
NCT05551104Phase 3Recruiting
- Sponsor
- Loma Linda University
- Start
- May 2023
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifedipine GITS, labetalol in hypertension (HTN), sponsored by Loma Linda University. Started May 2023; status: recruiting.
02
Drugs
nifedipine GITSlabetalol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05551104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551104.